Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.
Related Posts
DRL, Emcure get approval to make breakthrough HIV drug
India’s drug regulator has cleared the path for local lenacapavir manufacturing. Two Indian pharmaceutical companies received waivers for local clinical trials. This move will improve access to the HIV prevention injection. Lenacapavir is a breakthrough twice-yearly injection for HIV prevention. Patient groups had urged the regulator to expedite this process.
Juicy yields pull junk bond ‘tourists’ towards high-grade AI debt
The fact that investment-grade rated projects are tapping junk debt investors to get at least some bond deals done underscores the feverish competition for capital
Anthropic says Iran, Russia used Claude for weapons research, including missile systems and kamikaze drone projects
Anthropic says users in Iran, Russia and other countries misused its Claude AI for weapons research, including missile systems and kamikaze drone swarms. The company also flagged attempts to use Claude for biological weapons research, surveillance and hacking.